ANTIGEN EXPRESS, INC.

Company Information

Company Name
ANTIGEN EXPRESS, INC.
Address
ANTIGEN EXPRESS, INC.
100 BARBER AVE
WORCESTER, MA, 01606
Phone
1 508-852-8801
URL
n/a
DUNS
n/a
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$2,177,097.00
9
Chart code to be here

Award List

  1. IIKEY PEPTIDE THERAPEUTICS

    Amount: $100,000.00

    A new class of immunotherapeutic drugs will be designed around the IiKEY peptide to enhance or inhibit, in an MHC class II allele related manner, immune responses in several disease states. Binding o ...

    SBIR Phase I 1997 Department of Health and Human Services
  2. N/A

    Amount: $173,340.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  3. PROSTATE CANCER VACCINE BY SUPPRESSING Ii PROTEIN

    Amount: $191,744.00

    DESCRIPTION: Suppressing the Ii protein by anti-sense oligonucleotides in MHC class Il-positive cancer cells creates a potent cancer cell vaccine. Presumably, additional determi ...

    SBIR Phase I 2001 Department of Health and Human Services
  4. COMBINED IL-2 AND MHC CLASS II GENE THERAPY FOR CANCER

    Amount: $287,382.00

    DESCRIPTION: Antigen Express has developed technology to force the presentation of endogenous tumor antigens in a manner that produces an effective tumor cell vaccine. The key to this strat ...

    SBIR Phase I 2001 Department of Health and Human Services
  5. HIV LI-KEY/PEPTIDE VACCINE

    Amount: $301,761.00

    Antigen Express scientists have discovered that a segment of the Ii protein called Ii-Key, which acts at an allosteric site on one end of the antigenic peptide binding site on MHC Class II molecules, ...

    SBIR Phase I 2002 Department of Health and Human Services
  6. li Suppression-enhanced HIV DNA Vaccine

    Amount: $354,100.00

    DESCRIPTION (provided by applicant): Antigen Express scientists have discovered that cells expressing MHC class II molecules in the absence of the MHC class II-associated Ii protein can act as effecti ...

    SBIR Phase I 2003 Department of Health and Human Services
  7. HER-2/neu T Helper/Memory Vaccine for Breast Cancer

    Amount: $224,700.00

    DESCRIPTION (provided by applicant): Antigen Express scientists have demonstrated that the li-Key segment of the li protein, acting at an allosteric site of Class II molecules, facilitates charging b ...

    SBIR Phase I 2003 Department of Health and Human Services
  8. li-Key/Melanoma MHC Class II Vaccines

    Amount: $444,070.00

    DESCRIPTION (provided by applicant): MHC-presented peptide vaccines are one of the most promising experimental therapies for melanoma. However, MHC class I peptides that prime CTLs lack dramatic anti- ...

    SBIR Phase I 2003 Department of Health and Human Services
  9. IMPROVING DNA VACCINES FOR HIV1

    Amount: $100,000.00

    N/A

    SBIR Phase I 1998 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government